A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/1997
11/13/1997	CA2253751A1 Improvement of implantation rates after in vitro fertilization
11/12/1997	CN1164414A Traditional Chinese medicine plaster for treatment of mastosis
11/12/1997	CN1036394C Method for preparation of carbostyril derivatives
11/12/1997	CN1036389C Phenylacetyl deriv. of 4-amino-2,6-dimethyl phenylsulfonyl-nitro-methane or preparing process thereof
11/11/1997	US5686476 Methods of inhibiting Alzheimer's Disease
11/11/1997	US5686098 Active substance patch for the release of estradiol to the skin
11/06/1997	WO1997041145A1 21-substituted progesterone derivatives as new antiprogestational agents
11/06/1997	WO1997041125A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
11/06/1997	WO1997041120A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
11/06/1997	WO1997041090A1 Inorganic ion receptor-active compounds
11/06/1997	WO1997040836A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
11/06/1997	WO1997040823A1 Oral pharmaceutical compositions containing sex hormones
11/06/1997	CA2668824A1 21-substituted progesterone derivatives as new antiprogestational agents
11/06/1997	CA2252876A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
11/05/1997	EP0804223A1 Hgh containing pharmaceutical compositions
11/05/1997	EP0804217A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
11/05/1997	EP0607400B1 Fluorinated 17-beta substituted-4-aza-5-alpha- andostran-3one derivatives.
10/1997
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	WO1997040062A1 Process for preparing steroids having a carboxamide side-chain
10/30/1997	WO1997040023A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
10/30/1997	CA2252761A1 Compounds with growth hormone releasing properties
10/30/1997	CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/29/1997	EP0802910A1 Estrogen agonists/antagonists
10/29/1997	EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997	CN1163571A Compositions containing at least one glucocorticoid in combination with pulmonary surfactant for treatment of IRDS and ARDS
10/28/1997	US5681817 Treatment of ovarian estrogen dependent conditions
10/23/1997	WO1997039123A2 Secreted proteins
10/23/1997	WO1997039032A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038981A1 NOVEL α-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
10/23/1997	CA2250757A1 Novel .alpha.-hydroxylic acid derivatives, their production and use
10/23/1997	CA2224859A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997	EP0802183A1 Estrogenic agents
10/21/1997	US5679685 Accelerated release composition containing bromocriptine
10/16/1997	WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	WO1997032588A3 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
10/16/1997	DE19614533A1 Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung New alpha-hydroxy-acid derivatives, their preparation and use
10/16/1997	CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/15/1997	EP0800519A1 Steroid receptor modulator compounds and methods
10/15/1997	EP0800386A1 Transdermal system for the simultaneous delivery of a number of active principles
10/15/1997	CN1161858A Chinese herbal medicine for treating thyreoidism
10/14/1997	US5676943 Nerve growth factor
10/09/1997	WO1997037015A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/09/1997	WO1997036596A1 Steroids as neurochemical initiators of change in human blood levels of lh or fsh
10/09/1997	CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997	EP0799206A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
10/08/1997	CN1161230A Medicine for treating centripetalis obesity
10/02/1997	WO1997035862A1 Azaspiroderivatives
10/02/1997	WO1997035861A1 Azaspiro derivatives
10/02/1997	DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/01/1997	EP0797564A1 Lignans, a process for their production and pharmaceutical compositions and uses thereof
10/01/1997	CN1036003C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
10/01/1997	CN1036002C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
09/1997
09/30/1997	US5672596 Animal growth controllers
09/30/1997	US5672584 Modified with end groups
09/25/1997	WO1997034924A1 Process and intermediates for the synthesis of lhrh antagonists
09/25/1997	WO1997034923A1 Process and intermediates for the synthesis of lhrh antagonists
09/25/1997	WO1997034901A1 Piperidine derivatives
09/25/1997	WO1997034900A1 Azaspiro derivatives
09/25/1997	CA2250016A1 Piperidine derivatives
09/24/1997	EP0796095A1 Methods of inhibiting growth hormone effects
09/24/1997	CN1160404A Pharmaceutical compositions contg. estra-1,3,5C10-triene derivs.
09/24/1997	CN1160045A Matrix metalloprotease inhibitors
09/18/1997	WO1997033901A1 Smooth muscle cell lim protein
09/18/1997	WO1997033589A1 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
09/18/1997	DE19610635A1 Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie Sequential estrogen / progesterone antagonist combination for hormone replacement therapy
09/18/1997	CA2248927A1 Smooth muscle cell lim protein
09/17/1997	EP0794961A2 Lhrh antagonist peptides
09/17/1997	EP0711164B1 4-aza-pregnane 5-alpha-reductase isozyme 1 inhibitors
09/17/1997	CN1159448A Benzothiophene compounds, intermediates, compositions, and methods
09/16/1997	US5668148 Benign prostatic hypertrophy
09/12/1997	WO1997032872A1 Compounds with a sulfamate group
09/12/1997	WO1997032588A2 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
09/12/1997	CA2248251A1 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination for the production of a pharmaceutical agent for treating a relative and absolute andrgen deficiency in men
09/11/1997	DE19610645A1 Kombination von Dehydroepiandrosteron und Aromatasehemmern und Verwendung dieser Kombination zur Herstellung eines Arzeimittels zur Behandlung eines relativen und absoluten Androgenmangels beim Mann Combination of dehydroepiandrosterone and aromatase inhibitors and the use of this combination being Arzeimittels for treating a relative and absolute androgen deficiency in men
09/10/1997	EP0619304B1 22-oxacholecalciferol derivative and production thereof
09/03/1997	EP0792289A1 Low molecular weight peptidomimetic growth hormone secretagogues
09/03/1997	CN1158622A Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
09/02/1997	US5663450 Promotes healing
09/02/1997	US5663345 Immunoregulatory, neuromuscular, joint and connective tissue disorders
09/02/1997	US5663146 Administering a synergistic combination to animals, including humans
09/02/1997	US5662936 Sugar-coated pharmaceutical dosage unit
08/1997
08/28/1997	WO1997031002A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
08/28/1997	WO1997030985A1 Benzothiophenes, and formulations and methods, using same
08/28/1997	WO1997030713A1 Method and composition for inhibiting cellular irreversible changes due to stress
08/28/1997	WO1997030709A1 Benzothiophenes, formulations containing same, and methods
08/28/1997	WO1997030656A1 Male contraceptive implant
08/28/1997	WO1997019953A3 New lh-rh antagonists with improved effectiveness
08/28/1997	WO1997009297A3 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
08/28/1997	CA2247461A1 Method and composition for inhibiting cellular irreversible changes due to stress
08/28/1997	CA2247130A1 Benzothiophenes, and formulations and methods, using same
08/28/1997	CA2246721A1 Benzothiophenes, formulations containing same, and methods
08/27/1997	EP0791603A2 Pure somatostatin antagonist and methods of use thereof
08/27/1997	EP0791591A1 Benzothiophenes, formulations containing same, and methods

1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 290